Bystander suppression to unrelated allergen sensitization through intranasal administration of tolerogenic exosomes in mouse.

Mol Immunol

Departamento de Bioquímica y Biología Molecular, Facultad de Química, Universidad Complutense, Madrid 28040, Spain.

Published: July 2010

AI Article Synopsis

  • Exosomes are tiny vesicles that can be used in vaccine design for allergies, specifically derived from bronchoalveolar lavage fluid (BALF) in a mouse model studying olive pollen allergies.
  • Researchers tested whether these exosomes, targeted at one allergen (Ole e 1), could also prevent sensitization to a different allergen (Bet v 1 from birch pollen).
  • The study found that pretreatment with these exosomes significantly reduced allergic responses, including decreased antibody levels and less lung inflammation, indicating a potential method for treating allergies by inducing tolerance.

Article Abstract

Exosomes represent a new family of bioactive nanovesicles (30-100 nm in diameter) secreted by different cell types whose appealing features can be exploited for designing vaccines in the context of several human diseases. We previously reported the potential of bronchoalveolar lavage fluid (BALF)-derived tolerogenic exosomes (Exo(Tol)) to be used as a nasal allergy vaccine in a mouse model of sensitization to Ole e 1, the main allergen of olive pollen. The aim of the study was to investigate whether such nanovesicles specific to Ole e 1 can also prevent the sensitization to other unrelated allergen, as Bet v 1 from birch pollen. Exo(Tol) were isolated from BALF of mice tolerized against Ole e 1 and used in a prophylactic approach. BALB/c mice were intranasally pretreated with Exo(Tol) one week before sensitization/challenge with Bet v 1, and the magnitude of allergen-specific response was analyzed. Intranasal pretreatment with Exo(Tol) resulted in significant inhibition of both specific IgE and IgG1 antibodies levels. Moreover, T cells from mice pretreated with Exo(Tol) showed a reduction in IL-5 and IL-13 (Th2 cytokines) production. Lung inflammatory response triggered by unrelated allergen-challenge was also significantly reduced after pretreatment: perivascular/peribronchial inflammatory cell infiltration, eosinophilia and mucus secretion. In conclusion, Exo(Tol) specific to Ole e 1, in addition to inhibit specific immune response to this allergen, blocked the allergic response to a second unrelated allergen such as Bet v 1. The in vivo "bystander suppression" that we herein describe for Exo(Tol) may have implications for the treatment of allergy based on mucosal tolerance induction.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molimm.2010.04.014DOI Listing

Publication Analysis

Top Keywords

unrelated allergen
12
tolerogenic exosomes
8
specific ole
8
allergen bet
8
pretreated exotol
8
exotol
7
allergen
5
bystander suppression
4
unrelated
4
suppression unrelated
4

Similar Publications

Flow cytometry-based basophil and mast cell activation tests in allergology: State of the art.

J Allergy Clin Immunol

November 2024

Immunology-Allergology-Rheumatology, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp University Hospital, and Infla-Med Centre of Excellence Antwerp University, Antwerp, Belgium.

The major challenge in allergy diagnosis is development of accessible and reliable diagnostics that can predict the clinical outcome following exposure to culprit allergen(s) or cross-reactive molecules and identification of safer alternatives than the current state-of-the-art methods. There is accumulating evidence that flow-based analyses for the quantification of activated basophils and mast cells subsequent to in vitro challenge (the basophil and mast cell activation test [BAT/MAT] or basophil activation test [BAT] and mast cell activation test [MAT]) could meet the diagnostic requirements for IgE-dependent allergies, drug hypersensitivities, and subsets of autoimmune urticaria. Furthermore, the BAT and MAT have found application in research and other nondiagnostic fields.

View Article and Find Full Text PDF

Early-Life Risk Factors and Clinical Features of Food Allergy Among Thai Children.

Int J Pediatr

October 2024

Division of Allergy and Immunology, Department of Pediatrics, Phramongkutklao Hospital and Phramongkutklao College of Medicine, 315 Rajavithi Road, Ratchathewi, Bangkok 10400, Thailand.

Food allergy affects 1%-10% of children under five worldwide, with genetic and early-life factors playing a primary role. Reported factors include a family history of allergic diseases, personal atopic dermatitis, cesarean section, dietary restrictions during pregnancy and lactation, and the timing of introducing solid foods. This study was aimed at identifying various factors associated with food allergy and evaluate each food allergy's clinical features.

View Article and Find Full Text PDF

The epithelial barrier theory and its associated diseases.

Allergy

December 2024

Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.

The prevalence of many chronic noncommunicable diseases has been steadily rising over the past six decades. During this time, over 350,000 new chemical substances have been introduced to the lives of humans. In recent years, the epithelial barrier theory came to light explaining the growing prevalence and exacerbations of these diseases worldwide.

View Article and Find Full Text PDF

Divergent sensory pathways of sneezing and coughing.

Cell

October 2024

Department of Anesthesiology, Washington University Pain Center, Washington University School of Medicine in St. Louis, St. Louis, MO 63110, USA. Electronic address:

Sneezing and coughing are primary symptoms of many respiratory viral infections and allergies. It is generally assumed that sneezing and coughing involve common sensory receptors and molecular neurotransmission mechanisms. Here, we show that the nasal mucosa is innervated by several discrete populations of sensory neurons, but only one population (MrgprC11MrgprA3) mediates sneezing responses to a multitude of nasal irritants, allergens, and viruses.

View Article and Find Full Text PDF

Neuromuscular blocking drugs (NMBAs) and Patent Blue V dye sodium salt 2.5% (Guerbet, Roissy, France) are frequently implicated in perioperative allergic immunoglobulin E (IgE) mediated anaphylaxis. Most cases of anaphylaxis during surgery occur at induction of anaesthesia, although reactions to vital dyes injected into soft tissues often show a delayed onset.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!